Showing 7 posts of 7 posts found.

FDA approves Roche’s Actemra/RoActemra treatment for rare lung disease

March 5, 2021
Medical Communications Actemra, RoActemra, Roche, SEC, systemic sclerosis

Roche’s Actemra/RoActemra therapy, intended for slowing the rate of decline in pulmonary function for adults with systemic sclerosis-associated interstitial lung …

US DoJ launch investigation into Acadia Pharmaceuticals

March 11, 2019
Sales and Marketing False Claims Act, SEC, acadia, antipsychotics, kickbacks

The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …

Sanofi to pay $25m over Kazakhstan and Middle East corruption allegations

September 5, 2018
Research and Development Kazakhstan, SEC, Sanofi, allegations, corruption, middle east

French pharma giant Sanofi will pay more than $25 million to settle corruption charges related to their subsidiaries in Kazakhstan …


Allergan fined £15m over failure to disclose merger discussions

January 19, 2017
Sales and Marketing Allergan, SEC

Allergan has been fined $15 million by the Security and Exchange Commission (SEC) after committing disclosure violations during merger talks …

AstraZeneca to pay £5.52 million to settle bribery probe

August 31, 2016
Research and Development AstraZeneca, SEC, misconduct

According to US regulators, AstraZeneca is to pay $5.52 million to resolve a foreign bribery probe investigating payments made to …

Mylan image

Mylan shells out $32.5m to cover tax inversion fines

December 11, 2014
Sales and Marketing AbbVie, Abbott, Mylan, SEC, bresch, coury

Mylan will pay five of its top executives an early $32.5 million to cover penalties from the company’s plans to …


GSK’s Stiefel accused of shares fraud

December 13, 2011
Sales and Marketing GSK, SEC, Stiefel, fraud

The US financial regulator has charged a subsidiary of GlaxoSmithKline with defrauding staff by buying back shares from them at …

Latest content